NICE’s recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in England and Wales an option beyond docetaxel.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nice-endorses-oral-alternative-chemo-prostate-cancer-2025a1000t05?src=rss
Author :
Publish date : 2025-10-24 11:27:00
Copyright for syndicated content belongs to the linked Source.
